Views & Analysis Why pharma needs to care about global warming Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by some media outlets) being in the news.
Oncology Advancing the frontiers of cancer diagnostics: Post-ASCO wit... Post-ASCO 2025, Eric Matthews, chief business officer at Caris Life Sciences, discusses advancing the frontier of cancer diagnostics and treatment.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face